Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial.
Felten R, Devauchelle-Pensec V, Seror R, Duffau P, Saadoun D, Hachulla E, Pierre Yves H, Salliot C, Perdriger A, Morel J, Mékinian A, Vittecoq O, Berthelot JM, Dernis E, Le Guern V, Dieudé P, Larroche C, Richez C, Martin T, Zarnitsky C, Blaison G, Kieffer P, Maurier F, Dellal A, Rist S, Andres E, Contis A, Chatelus E, Sordet C, Sibilia J, Arnold C, Tawk MY, Aberkane O, Holterbach L, Cacoub P, Saraux A, Mariette X, Meyer N, Gottenberg JE. Felten R, et al. Among authors: zarnitsky c. Ann Rheum Dis. 2021 Mar;80(3):329-338. doi: 10.1136/annrheumdis-2020-218467. Epub 2020 Nov 18. Ann Rheum Dis. 2021. PMID: 33208345 Clinical Trial.
Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial.
Soubrier M, Puéchal X, Sibilia J, Mariette X, Meyer O, Combe B, Flipo RM, Mulleman D, Berenbaum F, Zarnitsky C, Schaeverbeke T, Fardellone P, Dougados M. Soubrier M, et al. Among authors: zarnitsky c. Rheumatology (Oxford). 2009 Nov;48(11):1429-34. doi: 10.1093/rheumatology/kep261. Epub 2009 Sep 9. Rheumatology (Oxford). 2009. PMID: 19741011 Clinical Trial.
Serum IgA rheumatoid factor and pyridinoline in very early arthritis as predictors of erosion(s) at two years: a simple model of prediction from a conservatively treated community-based inception cohort.
Le Loët X, Brazier M, Mejjad O, Boumier P, Daragon A, Gayet A, Pouplin S, Tron F, Zarnitsky C, Vittecoq O, Menard JF, Fardellone P. Le Loët X, et al. Among authors: zarnitsky c. Arthritis Care Res (Hoboken). 2010 Dec;62(12):1739-47. doi: 10.1002/acr.20321. Arthritis Care Res (Hoboken). 2010. PMID: 20740612 Free article.
Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry.
Gottenberg JE, Cinquetti G, Larroche C, Combe B, Hachulla E, Meyer O, Pertuiset E, Kaplanski G, Chiche L, Berthelot JM, Gombert B, Goupille P, Marcelli C, Feuillet S, Leone J, Sibilia J, Zarnitsky C, Carli P, Rist S, Gaudin P, Salliot C, Piperno M, Deplas A, Breban M, Lequerre T, Richette P, Ghiringhelli C, Hamidou M, Ravaud P, Mariette X; Club Rhumatismes et Inflammations and the French Society of Rheumatology. Gottenberg JE, et al. Among authors: zarnitsky c. Ann Rheum Dis. 2013 Jun;72(6):1026-31. doi: 10.1136/annrheumdis-2012-202293. Epub 2012 Dec 21. Ann Rheum Dis. 2013. PMID: 23264337
Treatment of primary Sjögren syndrome with rituximab: a randomized trial.
Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot JM, Perdriger A, Puéchal X, Le Guern V, Sibilia J, Gottenberg JE, Chiche L, Hachulla E, Hatron PY, Goeb V, Hayem G, Morel J, Zarnitsky C, Dubost JJ, Pers JO, Nowak E, Saraux A. Devauchelle-Pensec V, et al. Among authors: zarnitsky c. Ann Intern Med. 2014 Feb 18;160(4):233-42. doi: 10.7326/M13-1085. Ann Intern Med. 2014. PMID: 24727841 Clinical Trial.
Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial.
Gottenberg JE, Ravaud P, Puéchal X, Le Guern V, Sibilia J, Goeb V, Larroche C, Dubost JJ, Rist S, Saraux A, Devauchelle-Pensec V, Morel J, Hayem G, Hatron P, Perdriger A, Sene D, Zarnitsky C, Batouche D, Furlan V, Benessiano J, Perrodeau E, Seror R, Mariette X. Gottenberg JE, et al. Among authors: zarnitsky c. JAMA. 2014 Jul 16;312(3):249-58. doi: 10.1001/jama.2014.7682. JAMA. 2014. PMID: 25027140 Clinical Trial.
Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy.
Cornec D, Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot JM, Perdriger A, Puéchal X, Le Guern V, Sibilia J, Gottenberg JE, Chiche L, Hachulla E, Hatron PY, Goeb V, Hayem G, Morel J, Zarnitsky C, Dubost JJ, Seror R, Pers JO, Meiners PM, Vissink A, Bootsma H, Nowak E, Saraux A. Cornec D, et al. Among authors: zarnitsky c. Rheumatology (Oxford). 2015 Sep;54(9):1699-708. doi: 10.1093/rheumatology/kev114. Epub 2015 May 8. Rheumatology (Oxford). 2015. PMID: 25957440 Clinical Trial.
Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?
Devauchelle-Pensec V, Gottenberg JE, Jousse-Joulin S, Berthelot JM, Perdriger A, Hachulla E, Hatron PY, Puechal X, Le Guern V, Sibilia J, Chiche L, Goeb V, Vittecoq O, Larroche C, Fauchais AL, Hayem G, Morel J, Zarnitsky C, Dubost JJ, Dieudé P, Pers JO, Cornec D, Seror R, Mariette X, Nowak E, Saraux A. Devauchelle-Pensec V, et al. Among authors: zarnitsky c. PLoS One. 2015 Sep 14;10(9):e0133907. doi: 10.1371/journal.pone.0133907. eCollection 2015. PLoS One. 2015. PMID: 26368934 Free PMC article.
Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial.
Cornec D, Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot JM, Perdriger A, Puéchal X, Le Guern V, Sibilia J, Gottenberg JE, Chiche L, Hachulla E, Yves Hatron P, Goeb V, Hayem G, Morel J, Zarnitsky C, Dubost JJ, Saliou P, Pers JO, Seror R, Saraux A. Cornec D, et al. Among authors: zarnitsky c. Arthritis Care Res (Hoboken). 2017 Apr;69(4):528-535. doi: 10.1002/acr.22974. Arthritis Care Res (Hoboken). 2017. PMID: 27390310 Clinical Trial.
Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical Trial.
Gottenberg JE, Brocq O, Perdriger A, Lassoued S, Berthelot JM, Wendling D, Euller-Ziegler L, Soubrier M, Richez C, Fautrel B, Constantin AL, Mariette X, Morel J, Gilson M, Cormier G, Salmon JH, Rist S, Lioté F, Marotte H, Bonnet C, Marcelli C, Sellam J, Meyer O, Solau-Gervais E, Guis S, Ziza JM, Zarnitsky C, Chary-Valckenaere I, Vittecoq O, Saraux A, Pers YM, Gayraud M, Bolla G, Claudepierre P, Ardizzone M, Dernis E, Breban MA, Fain O, Balblanc JC, Aberkane O, Vazel M, Back C, Candon S, Chatenoud L, Perrodeau E, Sibilia J, Ravaud P. Gottenberg JE, et al. Among authors: zarnitsky c. JAMA. 2016 Sep 20;316(11):1172-1180. doi: 10.1001/jama.2016.13512. JAMA. 2016. PMID: 27654603
40 results